J. Egan

723 total citations
23 papers, 551 citations indexed

About

J. Egan is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, J. Egan has authored 23 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in J. Egan's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Transplantation: Methods and Outcomes (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). J. Egan is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Transplantation: Methods and Outcomes (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). J. Egan collaborates with scholars based in United Kingdom, Ireland and United States. J. Egan's co-authors include Ashley Woodcock, P S Hasleton, James P. Stewart, K B Carroll, J. R. Arrand, Julius M. Gardin, Antonio Colombo, Harold G. Olson, P S Hasleton and She Lok and has published in prestigious journals such as European Respiratory Journal, Thorax and Osteoporosis International.

In The Last Decade

J. Egan

23 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Egan United Kingdom 11 328 113 104 97 78 23 551
Veli Yazısız Türkiye 16 104 0.3× 81 0.7× 198 1.9× 137 1.4× 37 0.5× 44 659
Akira Shiraki Japan 12 314 1.0× 76 0.7× 142 1.4× 42 0.4× 52 0.7× 33 531
S Sandhyamani India 10 105 0.3× 74 0.7× 15 0.1× 103 1.1× 34 0.4× 41 303
Frank C. Astor United States 11 79 0.2× 48 0.4× 106 1.0× 197 2.0× 47 0.6× 27 449
Jason M. Golbin United States 9 593 1.8× 53 0.5× 306 2.9× 76 0.8× 15 0.2× 14 738
James C. Burns United States 13 67 0.2× 93 0.8× 52 0.5× 273 2.8× 81 1.0× 24 780
Thomas Q. Gallagher United States 10 168 0.5× 70 0.6× 129 1.2× 167 1.7× 37 0.5× 34 451
Jaya Deshpande India 13 91 0.3× 156 1.4× 27 0.3× 151 1.6× 27 0.3× 48 531
Funda Erbasan Türkiye 11 62 0.2× 48 0.4× 182 1.8× 104 1.1× 41 0.5× 27 428
J A van Oostayen Netherlands 11 109 0.3× 74 0.7× 12 0.1× 224 2.3× 68 0.9× 19 437

Countries citing papers authored by J. Egan

Since Specialization
Citations

This map shows the geographic impact of J. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Egan more than expected).

Fields of papers citing papers by J. Egan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Egan. The network helps show where J. Egan may publish in the future.

Co-authorship network of co-authors of J. Egan

This figure shows the co-authorship network connecting the top 25 collaborators of J. Egan. A scholar is included among the top collaborators of J. Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Egan. J. Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Reilly, A., et al.. (2017). The efficacy and safety of bronchial thermoplasty in severe persistent asthma on extended follow-up. QJM. 111(3). 155–159. 9 indexed citations
2.
Egan, J., et al.. (2016). The Efficacy of Bronchial Thermoplasty for Severe Persistent Asthma: The First National Experience.. PubMed. 109(5). 406–406. 8 indexed citations
3.
Perry, Audrey, F.K. Gould, Malcolm Brodlie, et al.. (2015). 59 Ralstonia mannitolilytica – an emerging threat in cystic fibrosis and lung transplantation. Journal of Cystic Fibrosis. 14. S72–S72. 3 indexed citations
4.
Minnis, Paul, et al.. (2014). P242 Pirfenidone As A Bridge To Lung Transplantation In Patients With Progressive Ipf. Thorax. 69(Suppl 2). A183–A183. 7 indexed citations
5.
Healy, David, J. Egan, Niall Mahon, et al.. (2006). The first 20 years of heart transplantation in Ireland. Irish Journal of Medical Science (1971 -). 175(1). 5–9. 3 indexed citations
6.
Freeburn, Robin, et al.. (2003). Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis. Genes and Immunity. 4(4). 258–264. 24 indexed citations
7.
Howell, David C., Richard P. Marshall, Neil Goldsack, et al.. (2002). The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats: Fig. 1.—. European Respiratory Journal. 19(6). 1124–1127. 80 indexed citations
8.
Lok, She, James P. Stewart, B. Kelly, P S Hasleton, & J. Egan. (2001). Epstein–Barr virus and wild p53 in idiopathic pulmonary fibrosis. Respiratory Medicine. 95(10). 787–791. 27 indexed citations
9.
Heras, M. De las, Sanford H. Barsky, P S Hasleton, et al.. (2000). Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours. European Respiratory Journal. 16(2). 330–330. 53 indexed citations
10.
Lok, She & J. Egan. (2000). Viruses and idiopathic pulmonary fibrosis.. PubMed. 55(2). 146–50. 18 indexed citations
11.
Egan, J., Claire Maden, Sanjay Kalra, et al.. (1999). A randomized, double‐blind study comparing the effects of beclomethasone and fluticasone on bone density over two years. European Respiratory Journal. 13(6). 1267–1267. 47 indexed citations
12.
Hasleton, P S, A. Curry, Paul Bishop, et al.. (1998). Differentiation of desquamative interstitial pneumonia (DIP) from pulmonary adenocarcinoma by immunocytochemistry. Histopathology. 33(2). 129–135. 11 indexed citations
13.
El‐Gamel, Adam, N. Yonan, Brian Keevil, et al.. (1998). Does Cyclosporin Promote the Secretion of Transforming Growth Factor-Beta 1 Following Pulmonary Transplantation?. Transplantation Proceedings. 30(4). 1525–1527. 14 indexed citations
14.
Egan, J. & Ashley Woodcock. (1996). Does the treatment of cryptogenic fibrosing alveolitis influence prognosis?. Respiratory Medicine. 90(3). 127–130. 9 indexed citations
15.
Egan, J., et al.. (1994). Benign Paroxysmal Positional Vertigo. Journal of Neuroscience Nursing. 26(6). 330–335. 7 indexed citations
16.
Egan, J., Swinder Jeet Singh Kalra, & Ashley Woodcock. (1991). Pulmonary function in chronic renal failure: effect of dialysis and transplantation.. Thorax. 46(11). 861–861. 1 indexed citations
17.
Colombo, Antonio, Harold G. Olson, J. Egan, & Julius M. Gardin. (1988). Etiology and prognostic implications of a large pericardial effusion in men. Clinical Cardiology. 11(6). 389–394. 72 indexed citations
18.
Egan, J.. (1975). Use of the Lombard Response in Cases of Hysterical Aphonia. Archives of Otolaryngology - Head and Neck Surgery. 101(9). 557–557. 9 indexed citations
19.
Egan, J.. (1971). The Lombard Reflex: Historical Perspective. Archives of Otolaryngology - Head and Neck Surgery. 94(4). 310–312. 12 indexed citations
20.
Egan, J.. (1971). The Lombard reflex. Medical Entomology and Zoology. 94. 310–312. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026